Santen
Yu (Shawn) Xiang is a seasoned executive with extensive experience in the healthcare and pharmaceutical sectors. Currently serving as Corporate Officer and Head of China at Santen since June 2024, Yu has also co-founded the Hope for Rare Foundation, the first philanthropic organization in China focused on rare diseases. Yu’s previous roles include Chief Executive Officer at RareStone Group, where efforts were made to create an ecosystem for rare disease patients, and General Manager at Abbott Diabetes Care, where notable achievements include leading significant market growth and launching the FreeStyle Libre in Korea. Yu's background includes leadership positions at Novartis and McKinsey & Company, focusing on business growth and strategic development. Yu holds a PhD in Engineering from Yale University and a Bachelor's degree from Peking University.
This person is not in any teams
This person is not in any offices
Santen
7 followers
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.